BIODESIX INC
Biodesix, Inc. (NASDAQ: BDSX) is a leading diagnostic solutions company that transforms patient care through personalized diagnostics addressing critical clinical needs in lung disease and oncology. The company operates through two primary business segments: Biodesix Lung Diagnostic Testing and Biodesix Development… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What BIODESIX INC does
In the company’s own words
Biodesix, Inc. (NASDAQ: BDSX) is a leading diagnostic solutions company that transforms patient care through personalized diagnostics addressing critical clinical needs in lung disease and oncology. The company operates through two primary business segments: Biodesix Lung Diagnostic Testing and Biodesix Development Services.
The Lung Diagnostic Testing segment provides five blood-based tests that support the continuum of lung cancer care, from initial nodule risk assessment through treatment guidance and disease monitoring. The Nodify Lung portfolio includes the Nodify CDT and Nodify XL2 proteomic tests for lung nodule risk stratification, while the IQLung testing strategy comprises the VeriStrat immune profiling test and GeneStrat ddPCR and GeneStrat NGS tumor profiling tests for treatment guidance in non-small cell lung cancer patients. These tests leverage proprietary proteomic and genomic technologies combined with artificial intelligence to deliver rapid, actionable diagnostic information to physicians.
The Development Services segment provides comprehensive diagnostic testing services and consulting to biopharmaceutical, life sciences, and diagnostic companies. This division offers end-to-end solutions including translational research, biomarker discovery, assay design and validation, clinical trial testing, regulatory support, and commercialization assistance. The company has served over 65 industry clients and academic research partners through this segment.
Biodesix operates two CLIA-certified, CAP-accredited clinical laboratories: one in Louisville, Colorado handling VeriStrat, GeneStrat ddPCR, and GeneStrat NGS testing, and another in De Soto, Kansas processing Nodify CDT and Nodify XL2 tests. The company employs a specialized commercial team focused on pulmonology specialists and primary care referral networks to drive adoption of its diagnostic tests.
The company's intellectual property strategy includes patents, trade secrets, and licensing agreements, notably including a non-exclusive license with Bio-Rad for Droplet Digital PCR technology. Biodesix maintains strategic partnerships with leading academic institutions including Memorial Sloan Kettering Cancer Center and collaborates with industry consortia to advance diagnostic innovation. The company's website is www.biodesix.com.
Company details
- Sector
- Healthcare
- Industry
- Health Services
- Headquarters
- LOUISVILLE, CO
- Fiscal year end
- December
- CIK
- 1439725
- SIC
- 8071
Financial performance, year by year
Fiscal 2020–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns BIODESIX INC — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · BIODESIX INC’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do BIODESIX INC and its peers compare on margins and cash generation over ten years?”
- “Where did five years of BIODESIX INC's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in BIODESIX INC's last four quarterly filings that the numbers alone won't show?”